There’s very little research on whether medications are safe and effective in pregnant and lactating women, but an expert panel has ideas for how to close that information gap — and it’s calling on the federal government to take action in a new report that could stir change.

The sweeping report is the product of more than a year of public meetings by a task force formed by Congress in 2016 to study why so few women can get reliable answers on medication use while pregnant and lactating. More than 6 million women are pregnant in the U.S. each year, and it’s estimated that more than 90 percent take at least one medication while pregnant or lactating. But few drugs have been approved as safe and effective to use during pregnancy.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Studying drug concentrations in breast milk could be done by acquiring milk from women who are stopping breastfeeding but still producing milk. Every lactating woman has a time when she’s not feeding her baby with the milk she produces. Why don’t drug companies pay these women to keep lactating?

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy